Condition: Chronic Obstructive Pulmonary Disease (COPD) · Sponsor: Bambusa Therapeutics
This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants with Chronic Obstructive Pulmonary Disease (COPD).
This description comes directly from the study's public registry record.
Tracy Ji, Study Director · +86 18001322760 · tracy.ji@bambusatx.com
Always discuss trial participation with your own doctor first.
| The Second Hospital of Anhui Medical Univesity | Hefei, Anhui, China | Recruiting |
| The third affiliated hosptial of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Guangdong Medical University | Guangzhou, Guangdong, China | Recruiting |
| Jiangmen Central Hospital | Jiangmen, Guangdong, China | Recruiting |
| Qingyuan People's Hospital | Qingyuan, Guangdong, China | Recruiting |
| The First People's Hospital of Xinxiang City | Xinxiang, Henan, China | Recruiting |
| Yichang Central People's Hospital | Yichang, Hubei, China | Recruiting |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou, Jiangsu, China | Recruiting |
| Jiangxi Provincial People's Hospital | Nanchang, Jiangxi, China | Recruiting |
| Chengdu fifth People's Hospital | Chengdu, Sichuang, China | Recruiting |
| Zhejiang Provincial People's Hospital | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07288554